Join the Jynneos group to help and get support from people like you.
Jynneos News
Bavarian Nordic Receives U.S. FDA Approval of Jynneos Freeze-Dried Smallpox and Mpox Vaccine
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of Jynneos® (Smallpox a...
Who's Most Likely to Get the Mpox Shot in U.S.?
FRIDAY, Dec. 13, 2024 – When an outbreak of mpox first hit the United States in 2022, a vaccine called Jynneos was available to help protect the most vulnerable population, gay and bisexual men....
First U.S. Case of New Mpox Strain Spotted in Traveler
MONDAY, Nov. 18, 2024 – As Africa continues to battle an outbreak of the newer "clade Ib" strain of mpox, California officials have confirmed the first known U.S. case of this strain of the virus....
U.K. Reports First Cluster Outside of Africa of New Mpox Variant
THURSDAY, Nov. 7, 2024 – Four cases of the more infectious variant of mpox have been reported in the U.K., making it the first cluster of infections that have surfaced outside of Africa. British...
Mpox Spread in Congo May Be Slowing
TUESDAY, Nov. 5, 2024 – In an early sign that the mpox outbreak in Africa might be ebbing, some health officials report that case counts seem to be stabilizing in the Congo, the epicenter of the...
Immunity From Mpox Vaccine May Be Waning
FRIDAY, Oct. 4, 2024 – Immunity against mpox may be waning for those vaccinated with the modified vaccinia Ankara-Bavarian Nordic (MVA-BN; Jynneos) vaccine, according to a research letter published...
Mpox Vaccine's Protection Wanes Within 1 Year; Boosters Needed
FRIDAY, Oct. 4, 2024 – Antibodies provided by mpox vaccination all but disappear within six to 12 months, new research finds, underscoring the need for boosters to maintain strong protection. Mpox...
First Doses of Mpox Vaccine Reach Africa, But Many More Are Needed
FRIDAY, Sept. 6, 2024 – As mpox continues to spread in Africa, Congolese authorities said Thursday that the first batch of vaccines have arrived in that country's capital. The shipment comes three...
Moderna's mRNA- Based Mpox Vaccine Shows Promise in Monkey Trial
WEDNESDAY, Sept. 4, 2024 – Current vaccines against mpox were designed to fight an older, rarer cousin of the virus, smallpox. Now, new research from the drug company Moderna suggests its new mpox...
WHO Unveils Plan to End African Mpox Outbreak
TUESDAY, Aug. 27, 2024 – As an mpox outbreak continues to rage in Africa, the World Health Organization on Monday launched a six-month plan to quell its spread. “The mpox outbreaks in the Democratic ...
Congo Says First Vaccines to Fight Mpox Arriving Next Week
WEDNESDAY, Aug. 21, 2024 – The first mpox vaccine doses from the United States are set to arrive next week in the Congo, the epicenter of an ongoing mpox outbreak in Africa. The doses come not a...
WHO Declares Africa Mpox Outbreak a Global Health Emergency
THURSDAY, Aug. 15, 2024 – The World Health Organization on Wednesday made the rare move of declaring an ongoing African outbreak of mpox a global health emergency. A new clade (strain) of the virus,...
Monkeypox Update: FDA Authorizes Emergency Use of Jynneos Vaccine to Increase Vaccine Supply
August 09, 2022 – Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Jynneos vaccine to allow healthcare providers to use the vaccine by intradermal...
FDA Approves Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults
COPENHAGEN, Denmark, September 24, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the U.S. Food and Drug Administration (FDA) has approved Jynneos™ (Smallpox and Monkeypox Vac...